054180 — Medicox Co Balance Sheet
0.000.00%
- KR₩36bn
- KR₩37bn
- KR₩27bn
Annual balance sheet for Medicox Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,708 | 3,140 | 18,742 | 24,768 | 17,689 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,386 | 2,320 | 2,517 | 4,280 | 3,901 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,138 | 7,131 | 26,273 | 43,389 | 30,037 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 43,355 | 46,533 | 46,960 | 48,516 | 51,476 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 56,062 | 84,890 | 102,479 | 110,434 | 96,691 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18,993 | 43,414 | 33,417 | 44,154 | 30,639 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 34,838 | 46,992 | 36,275 | 47,194 | 34,455 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 21,224 | 37,898 | 66,204 | 63,240 | 62,236 |
Total Liabilities & Shareholders' Equity | 56,062 | 84,890 | 102,479 | 110,434 | 96,691 |
Total Common Shares Outstanding |